SCIENCE SUPPORTING ORAL HYALURONIC ACID
Hyaluronic Acid – General
◊ Increasing chondrocyte density – Guidolin et al
◊ Promoting synovium metabolism – Maniwa et al
◊ Normalizing synovial fluid – Asari et al
◊ Treating sharp pain – Day et al
Therefore, there is extensive scientific support confirming HA has a strong relationship with knee joint health.
Oral Absorption of Hyaluronic Acid
◊ 13.3% of the oral dose was absorbed and taken up in joints and connective tissue
◊ Scintigraphy scan of the dog chest showing distribution of hyaluronic acid in the joints, bones and salivary glands two hours after administration
◊ Scintigraphic scan of rat chest showing distribution in joints, bones, muscles and salivary glands 4 hours after administration
Mechanism Of Oral Hyaluronic Acid Treatment For Knee Pain
◊ Enhancing the production of the IL-10 an anti-inflammatory cytokine
◊ Up regulates suppressor of SOCS3 cytokine expression and down regulates an inflammatory cytokine pleiotrophin
These results indicate that HA absorption in the intestine contributes to reduced inflammation in arthritis – Asari et al
◊ Inflammatory cytokine levels were significantly increased in the placebo group (p<0.05) and significantly reduced in the HA group (P<0.05)
◊ Bradykinin, which relates to inflammation and pain, and leptin, which is related to osteoarthritis caused by obesity, the levels of both substances were significantly lower in the HA group than the placebo group (P<0.05)
Use Of Oral Hyaluronic Acid In Horses
◊ Baseline blood samples taken at the beginning of the study
◊ Daily blood samples taken for 7 days
◦ Oral group
◦ Intravenous group
◦ Control group
◊ 48 yearlings divided into 2 groups, 100 mg of HA daily and control
◊ HA significantly reduced joint swelling compared to no treatment
◊ 100 mg of hyaluronic acid administered orally daily
◊ There was a reduced number of times veterinarians were asked to examine racing thoroughbreds for lameness
 Balazs EA, Watson D, Duff IF, Roseman S. Hyaluronic acid in synovial fluid. I. Molecular parameters of hyaluronic acid in normal and arthritic human fluids. Arthritis Rheum. 1967;10:357-76. doi: 10.1002/art.1780100407.
 Seror J, Merkher Y, Kampf N, Collinson L, Day AJ, Maroudas A, et al. Articular cartilage proteoglycans as boundary lubricants: structure and frictional interaction of surface-attached hyaluronan and hyaluronan--aggrecan complexes. Biomacromolecules. 2011;12:3432-43. doi: 10.1021/bm2004912.
 Ghosh P, Holbert C, Read R, Armstrong S. Hyaluronic acid (hyaluronan) in experimental osteoarthritis. J Rheumatol Suppl. 1995;43:155-7.
 Schiavinato A, Lini E, Guidolin D, Pezzoli G, Botti P, Martelli M, et al. Intraarticular sodium hyaluronate injections in the Pond-Nuki experimental model of osteoarthritis in dogs. II. Morphological findings. Clin Orthop Relat Res. 1989;241:286-99.
 Frizziero L, Govoni E, Bacchini P. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: clinical and morphological study. Clin ExpRheumatol. 1998;16:441-9.
 Pasquali Ronchetti I, Guerra D, Taparelli F, Boraldi F, Bergamini G, Mori G, et al. Morphological analysis of knee synovial membrane biopsies from a randomized controlled clinical study comparing the effects of sodium hyaluronate (Hyalgan) and methylprednisolone acetate (Depomedrol) in osteoarthritis. Rheumatology. 2001;40:158-69. doi: 10.1093/rheumatology/40.2.158.
 Guidolin DD, Ronchetti IP, Lini E, Guerra D, Frizziero L. Morphological analysis of articular cartilage biopsies from a randomized, clinical study comparing the effects of 500-730 kDa sodium hyaluronate (Hyalgan) and methylprednisolone acetate on primary osteoarthritis of the knee. Osteoarthritis Cartilage. 2001;9:371-81. doi: 10.1053/joca.2000.0398.
 Maniwa S, Ochi M, Motomura T, Nishikori T, Chen J, Naora H. Effects of hyaluronic acid and basic fibroblast growth factor on motility of chondrocytes and synovial cells in culture. Acta Orthop Scand, 2001;72:299-303. doi: 10.1080/00016470152846664.
 Asari A, Miyauchi S, Matsuzaka S, Ito T, Kominami E, Uchiyama Y. Molecular eight-dependent effects of hyaluronate on the arthritic synovium. Arch Histol Cytol. 1998;61:125-35. doi: 10.1679/aohc.61.125.
 Day R, Brooks P, Conaghan PG, Petersen M. A double blind, randomized, multicenter, parallel group study of the effectiveness and tolerance of intraarticular hyaluronan in osteoarthritis of the knee. J Rheumatol. 2004;31:775-82.
 Balogh L, Polyak A, Mathe D, Kiraly R, Thuroczy J, Terez M, et al. Absorption, uptake and tissue affinity of high-molecular-weight hyaluronan after oral administration in rats and dogs. J Agric Food Chem. 2008;56:10582-93. doi: 10.1021/jf8017029.
 Santangelo KS, Johnson AL, Ruppert AS, Bertone AL. Effects of hyaluronan treatment on lipopolysaccharide-challenged fibroblast-like synovial cells. Arthritis Res Ther. 2007;9:R1. doi: 10.1186/ar2104.
 Ikeda K. Changes in synovial fluid markers and clinical effects after intra-articular injection of sodium hyaluronate with particular reference to the anti-inflammatory effect in terms of prostaglandin E2 concentration. Tokyo Women’s Medical University. 1998;68:22-36.
 Asari A, Kanemitsu T, Kurihara H. Oral administration of high molecular weight hyaluronan (900 kDa) controls immune system via Toll-like receptor 4 in the intestinal epithelium. J Biol Chem. 2010;285:24751-8. doi: 10.1074/jbc.M110.104950.
 Nelson FR, Zvirbulis RA, Zonca B, Li KW, Turner SM, Pasierb M, et al. The effects of an oral preparation containing hyaluronic acid (Oralvisc) on obese knee osteoarthritis patients determined by pain, function, bradykinin, leptin, inflammatory cytokines, and heavy water analyses. Rheumatol Int. 2015;35:43-52. doi: 10.1007/s00296-014-3047-6.
Bergin BJ, Pierce SW, Bramlage LR, Stromberg A. Oral hyaluronan gel reduces post operative tarso crural effusion in the yearling thoroughbred. Equine Vet J. 2006;38(4):375-8